ABBOTT
ActiveSummary
ABBOTT has been active since 1948 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.10bn and a net result of €369.8m. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 93% of 6,055 sector peers (NACE 46, fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Board 1
Day-to-day management 1
Not every act has been read: a resignation may be missing here
Mandate history
- Board
- Day-to-day management
- began earlier
| Name | Functions and periods |
|---|---|
| Maya Abdel Ahad Wakim |
|
| Hendrikus Lueb |
|
Owners and capital
Owners
3 ownersChain of control
- ABBOTT LABORATORIESUS
- ABBOTT
Highest known parent: ABBOTT LABORATORIES (United States). The sources do not say who stands above it.
Owners 3
- St Jude Medical International HoldingLUparentSourceown accounts 2025100%
- ABBOTT LABORATORIESUSparentSourceLEI registerconsolidated
- Abbott Holding Gibraltar LimitedMTSourceown accounts 20250%
According to the 2025 annual accounts of ABBOTT and those of the other companies, the acts in the Belgian Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Companies Code and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.